Hypercoagulopathy in Severe COVID-19: Implications for Acute Care.

Waite, Alicia AC ORCID: 0000-0001-8734-994X, Hamilton, David O, Pizzi, Roberto, Ageno, Walter and Welters, Ingeborg D ORCID: 0000-0002-3408-8798
(2020) Hypercoagulopathy in Severe COVID-19: Implications for Acute Care. Thrombosis and Haemostasis, 120 (12). 1654 - 1667.

Access the full-text of this item by clicking on the Open Access link.


COVID-19 was first described in late 2019 and has since developed into a pandemic affecting more than 21 million people worldwide. Of particular relevance for acute care is the occurrence of COVID-19-associated coagulopathy (CAC), which is characterised by hypercoagulability, immunothrombosis and venous thromboembolism, and contributes to hypoxia in a significant proportion of patients. This review describes diagnosis and treatment of CAC in the emergency department and in intensive care. We summarise the pathological mechanisms and common complications of CAC such as pulmonary thrombosis and venous thromboembolic events and discuss current strategies for thromboprophylaxis and therapeutic anti-coagulation in the acute care setting.

Item Type: Article
Depositing User: Symplectic Admin
Date Deposited: 11 Jan 2021 10:22
Last Modified: 26 Feb 2021 08:36
DOI: 10.1055/s-0040-1721487
Open Access URL: https://www.thieme-connect.com/products/ejournals/...
URI: https://livrepository.liverpool.ac.uk/id/eprint/3112794